F. Märki - Concepedia

Author

F. Märki

Novartis (Switzerland)

Also Known As

F Märki, F. Marki, F. MÄRKI, F. Märki, FRITZ MÄRKI, FRITZ MÄRKI, Fritz MÄRKI, Fritz Märki, Marki, F

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)University of Turku University of Basel National Institute of Arthritis and Musculoskeletal and Skin Diseases

About

F. Märki is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.2K
2	Biochemistry	11	11	477
3	Natural Sciences	8	8	369
4	Allergy	3	3	158
5	Biology	2	2	138

F. Märki

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells Josef Pfeilschifter, W. Pignat, Klaus Vosbeck, Biochemical and Biophysical Research Communications InflammationCytokineTumor Necrosis FactorUrologyAnti-inflammatory	1989	191
Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2 F. Märki, Elvira Hänni, Andreas Fredenhagen, Biochemical Pharmacology Inhibitory ActivityMedicinal ChemistryAntibioticsBiochemistryIndirect Inhibitors	1991	141
Interleukin-1β, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells Casper G. Schalkwijk, Josef Pfeilschifter, F. Märki, Biochemical and Biophysical Research Communications InflammationCytokineTumor Necrosis FactorSignal TransductionApoptosis	1991	106
Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. Andreas Fredenhagen, Gabriele Fendrich, F. Märki, The Journal of Antibiotics	1990	103
Endogenous suppression of neutral-active and calcium-dependent phospholipase A2 in human polymorphonuclear leukocytes F. Märki, Richard Franson Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism InflammationCell PhysiologySignal TransductionGranulocyteCell Signaling	1986	102
The venom of the Colombian arrow poison frogPhyllobates bicolor F. Märki, Bernhard Witkop Cellular and Molecular Life Sciences BiologyToxicologyVenomicsToxinology	1963	95
Immunochemical Detection of Group I and Group II Phospholipases A2 in Human Serum Timo J. Nevalainen, P T Kortesuo, Esa Rintala, Clinical Chemistry Immunocytochemical TechniqueSignal TransductionAllergyAutoimmune DiseaseMedicine	1992	94
Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2. Casper G. Schalkwijk, Josef Pfeilschifter, F. Märki, Journal of Biological Chemistry ImmunologyCell GrowthGrowth Factor-beta 2Cellular PhysiologyEnzyme Secretion	1992	79
Studies on the acyl-chain selectivity of cellular phospholipases A2 Casper G. Schalkwijk, F. Märki, H. van den Bosch Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism Proteinlipid InteractionSignal TransductionBiochemistryNatural SciencesCellular Biochemistry	1990	78
Cytokine-and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone Casper G. Schalkwijk, Margriet J. Vervoordeldonk, Josef Pfeilschifter, Biochemical and Biophysical Research Communications InflammationCytokineProstaglandin E2Signal TransductionAnti-inflammatory	1991	62

Page 1